These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
687 related items for PubMed ID: 22223849
1. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. He X, Zheng Z, Li J, Ben Q, Liu J, Zhang J, Ji J, Yu B, Chen X, Su L, Zhou L, Liu B, Yuan Y. Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849 [Abstract] [Full Text] [Related]
2. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Xue A, Xue M, Jackson C, Smith RC. Int J Biochem Cell Biol; 2009 Mar; 41(8-9):1731-8. PubMed ID: 19433314 [Abstract] [Full Text] [Related]
3. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T. BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015 [Abstract] [Full Text] [Related]
4. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC. Pancreas; 2008 Mar 20; 36(2):160-7. PubMed ID: 18376307 [Abstract] [Full Text] [Related]
5. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM. Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945 [Abstract] [Full Text] [Related]
6. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Kargiotis O, Chetty C, Gogineni V, Gondi CS, Pulukuri SM, Kyritsis AP, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS. Int J Oncol; 2008 Nov 01; 33(5):937-47. PubMed ID: 18949356 [Abstract] [Full Text] [Related]
7. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer]. Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M. Ai Zheng; 2007 Jan 01; 26(1):48-53. PubMed ID: 17222367 [Abstract] [Full Text] [Related]
8. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells. Tanouchi A, Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Kimura M, Watanabe R, Kohsaki T, Shimizu T, Saito M, Hanazaki K, Saibara T. J Exp Clin Cancer Res; 2016 Dec 05; 35(1):190. PubMed ID: 27919290 [Abstract] [Full Text] [Related]
9. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Whitley BR, Beaulieu LM, Carter JC, Church FC. Gynecol Oncol; 2007 Feb 05; 104(2):470-9. PubMed ID: 17070899 [Abstract] [Full Text] [Related]
10. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K. Int J Oncol; 2006 Apr 05; 28(4):807-14. PubMed ID: 16525628 [Abstract] [Full Text] [Related]
11. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H, Kong R, Wang Y, Zhu H, He F, Xu Q, Liu L, Li M, Zhang S, Nagaoka K, Carlson R, Safran H, Charpentier K, Sun B, Wands J, Dong X. J Hematol Oncol; 2019 Dec 30; 12(1):144. PubMed ID: 31888763 [Abstract] [Full Text] [Related]
12. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS. Mol Cancer Res; 2011 Apr 30; 9(4):377-89. PubMed ID: 21389187 [Abstract] [Full Text] [Related]
13. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J. J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191 [Abstract] [Full Text] [Related]
14. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X. Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513 [Abstract] [Full Text] [Related]
15. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway. Zhu ZM, Li ZR, Huang Y, Yu HH, Huang XS, Yan YF, Shao JH, Chen HP. Oncol Rep; 2014 Mar 01; 31(3):1489-97. PubMed ID: 24398929 [Abstract] [Full Text] [Related]
16. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor. Raghu H, Gondi CS, Dinh DH, Gujrati M, Rao JS. Mol Cancer; 2011 Oct 17; 10():130. PubMed ID: 22004682 [Abstract] [Full Text] [Related]
17. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C, Yu J, Huang S. Mol Carcinog; 2007 Mar 17; 46(3):165-75. PubMed ID: 17186542 [Abstract] [Full Text] [Related]
18. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS. J Biol Chem; 2005 Oct 28; 280(43):36529-40. PubMed ID: 16127174 [Abstract] [Full Text] [Related]
19. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC. Wang L, Zhi X, Zhu Y, Zhang Q, Wang W, Li Z, Tang J, Wang J, Wei S, Li B, Zhou J, Jiang J, Yang L, Xu H, Xu Z. Oncotarget; 2015 Oct 20; 6(32):33805-22. PubMed ID: 26393880 [Abstract] [Full Text] [Related]
20. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Lee KH, Choi EY, Koh SA, Kim MK, Jang BI, Kim SW, Kim JR. Oncol Rep; 2014 May 20; 31(5):2123-30. PubMed ID: 24626561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]